Open AccessP390: ACUTE MYELOID LEUKEMIA SUPPRESSION BY PALBOCICLIB AND PONATINIB IN PATIENT‐DERIVED XENOGRAFT
Author(s) -
Busa D.,
Culen M.,
Loja T.,
Jeziskova I.,
Folta A.,
Mayer J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844448.69756.43
Subject(s) - venetoclax , azacitidine , medicine , myeloid leukemia , cytarabine , palbociclib , ponatinib , chemotherapy , oncology , leukemia , cancer , pharmacology , breast cancer , chronic lymphocytic leukemia , biology , dasatinib , metastatic breast cancer , imatinib , biochemistry , gene expression , dna methylation , gene